MRI around the time of diagnostic biopsy may identify patients at increased risk for early reclassification during prostate cancer active surveillance.

A new study finds that harms of overdiagnosing prostate cancer is lessened when MRI is used as well as PSA tests.

Omitting systematic biopsy in men with elevated prostate-specific antigen (PSA) levels and negative MRI results, and ...

Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced ...

Data on the efficacy and safety of screening for prostate cancer with magnetic resonance imaging (MRI) are needed from studies of follow-up screening. In a population-based trial that started in ...

Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer ...

Getting screened for cancer is a stressful experience, especially when the methods can be invasive. New research indicates ...

As Prostate Cancer Awareness Month comes to an end, a local doctor is reminding all men that prostate cancer awareness is ...

Detection of clinically insignificant ISUP grade group 1 prostate cancer decreases by 57% under a prostate cancer screening strategy of MRI-targeted biopsy only rather than systematic biopsy in men ...

Know about Prostate cancer as it has significant impact on men's health. Here are the details about this disease.

Omitting biopsy in patients with negative magnetic resonance imaging (MRI) results is associated with a significantly reduced ...